Cancer Communications
indexed by SCI
BMC

doi: 10.5732/cjc.011.10317
Establishment and characterization of a novel nasopharyngeal carcinoma cell line (SUNE2) from a Cantonese patient
Ju-Qin Dong, Man-Zhi Li, Zhi-Gang Liu, Qian Zhong, Dan Xiong, Li-Hua Xu, Yong Du, Yun-Fei Xia, Mu-Sheng Zeng
State Key Laboratory of Oncology in South China;Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China. zengmsh@mail.sysu.edu.cn
[Abstract] The undifferentiated form of nasopharyngeal carcinoma (NPC) is the most common malignant head and neck cancer in South China, especially in Cantonese populations. However, few NPC cell lines have been established from the patients in this region. In this study, we established a new NPC cell line, termed SUNE2, from a Cantonese patient with undifferentiated NPC. This cell line had extremely low concentrations of Epstein-Barr virus (EBV) DNA in long-term culture and expressed low levels of latent membrane protein 1 (LMP1), latent membrane protein 2A (LMP2A), BamH1-A right frame 1 (BARF1), EBV-encoded RNA-1 (EBER1), and EBV-encoded RNA-2 (EBER2) in early passages. SUNE2 cells also showed much stronger transforming ability than 5-8F cells in colony formation assays and anchorage-independent growth assays in soft agar, and they only need 2 weeks to form tumors in nude mice. In summary, the SUNE2 cell line is a new in vitro model that can be used for further research on the mechanisms underlying the occurrence and development of NPC.
Chinese Journal of Cancer 2012, Volume: 31, Issue 1, Page: 36-44
[ PDF Full-text ]
[ Html full-text ](PubMed Central)

[ PubMed ]

[Google Scholar]


Cite this article

Ju-Qin Dong, Man-Zhi Li, Zhi-Gang Liu, Qian Zhong, Dan Xiong, Li-Hua Xu, Yong Du, Yun-Fei Xia, Mu-Sheng Zeng. Establishment and characterization of a novel nasopharyngeal carcinoma cell line (SUNE2) from a Cantonese patient. Chin J Cancer. 2012, 31(1):36-44. doi:10.5732/cjc.011.10317


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China